Results 21 to 30 of about 662,770 (261)

Prognostic Value of Bone Marrow Uptake Using 18F-FDG PET/CT Scans in Solid Neoplasms

open access: yesJournal of Imaging, 2022
Background: Fluorine-18-fluorodeoxyglucose positron emission tomography/computerized tomography (18F-FDG PET/CT) uptake is known to increase in infective and inflammatory conditions. Systemic inflammation plays a role in oncologic prognosis. Consequently,
Francisco Tustumi   +6 more
doaj   +1 more source

Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study

open access: yesJournal of Orthopaedic Surgery and Research, 2020
Background Large population-based studies of risk factor for lung metastases at the presentation with primary osseous neoplasms are lacking and necessary.
Lin Xie   +4 more
doaj   +1 more source

Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis

open access: yesEndocrine Connections, 2021
Calcitonin-secreting neuroendocrine neoplasms of the lung are rare, with few cases reported in the literature. Differentiating between medullary th yroid carcinoma and an ectopic source of calcitonin secretion can represent a complex diagnostic conundrum
David C Llewellyn   +8 more
doaj   +1 more source

Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer

open access: yesChinese Journal of Lung Cancer, 2019
Background and objective Current research shows that platelet to lymphocyte ratio (PLR) has important prognostic value in renal cell carcinoma, esophageal cancer, gastric cancer, liver cancer and colon cancer.
Haoran CHEN   +5 more
doaj   +1 more source

The Spectrum of Lung and Pleural Neoplasms in Patients Presented to a Tertiary Care Hospital in Nepal

open access: yesJournal of Karnali Academy of Health Sciences, 2022
Background: Lung cancer is one of the most common cancers worldwide. Lung and pleural biopsies are the most commonly performed procedures for the diagnosis of suspicious lesions in the lungs and pleura.
Smritee Mahat   +2 more
doaj  

Multiple metachronous and synchronous malignancies with lung and thorax involvement. Report of two cases

open access: yesRespiratory Medicine Case Reports, 2018
Multiple primary malignant neoplasms (MPMN) is an uncommon phenomenon, while the diagnosis of such conditions is very significant. Considering that the strategy of the treatment is determined by the histological type of the tumor, practitioners should be
Konstantinos Sapalidis   +19 more
doaj   +1 more source

Lung Transplantation in Controlled Donation after Circulatory-Determination-of-Death Using Normothermic Abdominal Perfusion

open access: yesTransplant International
The main limitation to increased rates of lung transplantation (LT) continues to be the availability of suitable donors. At present, the largest source of lung allografts is still donation after the neurologic determination of death (brain-death donors ...
Paula Moreno   +7 more
doaj   +1 more source

Some correlations between eight types of malignant neoplasms: A hint from cancer dynamics of 31 European countries in 20 years [PDF]

open access: yesNetwork Biology, 2017
In present study, the data of standardised death rates of malignant neoplasms per 100000 inhabitants in 31 European countries during 1994-2013 were used to analyze linear correlations between eight types of cancers in terms of induced death rates.
WenJun Zhang
doaj  

Incidentally Detected Malignancies in Lung Transplant Explants

open access: yesTransplantation Direct, 2019
Background. Active malignancy diagnosed within 5 years is an absolute contraindication for lung transplantation. In this study, we evaluated the rate of incidental malignancies detected in explanted lungs at our institution and assessed the ...
Dhruv A. Amratia, MD   +3 more
doaj   +1 more source

Rapidly Progressive Lung Sarcomatoid Carcinoma Managed with Doxorubicin Plus Ifosfamide and Pemetrexed

open access: yesCase Reports in Oncology, 2021
Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of nonsmall-cell lung cancer (NSCLC). It carries a poor prognosis, even among other subtypes of NSCLC.
Jan Alberto Paredes Mogica   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy